title: Human papillomavirus evaluation of vemurafenib-induced skin epithelial tumors: a case series.
authors.affiliation: Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Dika
authors.forename: A
authors.initials: A
authors.lastname: Patrizi
authors.forename: S
authors.initials: S
authors.lastname: Venturoli
authors.forename: P A
authors.initials: PA
authors.lastname: Fanti
authors.forename: D
authors.initials: D
authors.lastname: Barbieri
authors.forename: R
authors.initials: R
authors.lastname: Strammiello
authors.forename: B
authors.initials: B
authors.lastname: Melotti
authors.forename: M
authors.initials: M
authors.lastname: La Placa
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced*; D005260:Female; D005838:Genotype; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D027383:Papillomaviridae / Q000235:genetics; D030361:Papillomavirus Infections; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors; D012878:Skin Neoplasms / Q000139:chemically induced*; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf